Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
-57.9K
-
Total reported value, excl. options
-
$651M
-
Value change
-
-$42.9M
-
Put/Call ratio
-
0.69
-
Number of buys
-
65
-
Number of sells
-
-45
-
Price
-
$17.69
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q4 2021
136 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 54M outstanding shares and own 68.14% of the company stock.
Largest 10 shareholders include FMR LLC (6.08M shares), TRV GP III, LLC (3.96M shares), RTW INVESTMENTS, LP (3.87M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.38M shares), TRV GP IV, LLC (2.34M shares), BlackRock Inc. (2.21M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.72M shares), VANGUARD GROUP INC (1.47M shares), Holocene Advisors, LP (865K shares), and D. E. Shaw & Co., Inc. (852K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.